Application value of high risk HPV DNA combined with TCT determination in preliminary screening of cervical cancer
10.3969/j.issn.1673-4130.2017.05.018
- VernacularTitle:高危型HPV DNA联合TCT检测在宫颈癌初筛中的应用价值
- Author:
Meiying WANG
;
Fen LI
;
Xilin DU
;
Wenjing ZHAO
;
Zhen ZHANG
- Keywords:
cervical cancer;
high risk human papillomavirus;
thinprep cytology test;
combined detection
- From:
International Journal of Laboratory Medicine
2017;38(5):620-621,624
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the application value of high risk human papillomavirus (HR HPV) DNA and thinprep cytolo-gy test(TCT ) detection in screening cervical cancer and to evaluate the clinical significance of their combined detection .Methods A total of 402 cases conducting cervical cancer screening in our hospital from March to May 2016 were selected and performed the HR HPV DNA and TCT detection .Those of suspected cervical lesions were performed the histopathological examination .Then the effects of HR HPV DNA and TCT combined detection were compared according to the pathological results .Results The detection positive rate of female HR HPV DNA was 27 .1% (109/402);abnormal and benign inflammation reaction were detected out in 46 cases of female TCT ,the positive rate was 11 .4% (46/402);in 123 cases of suspected cervical malignant lesion ,32 .5% females(40/123) appeared CIN Ⅰgrade or more lesions by histopathological examination ;the sensitivity of HR HPV DNA and TCT combined detection was higher than that of single detection ,the difference was statistically significant (P<0 .05);the specificity of HR HPV DNA and TCT combined detection was higher than that of HR HPV DNA single detection ,the difference was statistically signifi-cant(P<0 .05) ,but the difference was not statistically significant compared with TCT single detection (P>0 .05) .Conclusion The detection of HR HPV DNA and TCT is a good method for screening of cervical cancer ,the combined detection of HR HPV DNA and TCT can improve the detection rate of cervical precancerous lesion .
